Page last updated: 2024-10-16

quinacrine and Dyspnea

quinacrine has been researched along with Dyspnea in 2 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Dyspnea: Difficult or labored breathing.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dipper, A1
Jones, HE1
Bhatnagar, R1
Preston, NJ1
Maskell, N1
Clive, AO1
Kreuser, ED1

Reviews

2 reviews available for quinacrine and Dyspnea

ArticleYear
Interventions for the management of malignant pleural effusions: a network meta-analysis.
    The Cochrane database of systematic reviews, 2020, 04-21, Volume: 4

    Topics: Adult; Bleomycin; Doxycycline; Dyspnea; Fever; Humans; Iodine; Network Meta-Analysis; Pleural Effusi

2020
[Malignant pleural effusions. Pathophysiology, diagnosis and therapy].
    Deutsche medizinische Wochenschrift (1946), 1985, Sep-06, Volume: 110, Issue:36

    Topics: Absorption; Amylases; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Capillary Permea

1985